Source link : https://www.newshealth.biz/health-news/incentives-do-not-boost-prostate-cancer-active-surveillance/
TOPLINE: Active surveillance adoption for low-risk prostate cancer increased from 54% to 84% between 2015 and 2021. A commercial payer’s payment incentive program showed no significant impact on increasing active surveillance rates compared with pre-incentive levels. METHODOLOGY: A cohort study analyzed data from 15,273 men (median age, 65 years) with prostate cancer diagnosed through the […]
Author : News Health
Publish date : 2025-01-09 07:50:22
Copyright for syndicated content belongs to the linked Source.
Categories